X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (108511) 108511
Newsletter (1592) 1592
Magazine Article (433) 433
Newspaper Article (300) 300
Book Chapter (200) 200
Dissertation (92) 92
Book / eBook (84) 84
Conference Proceeding (54) 54
Reference (40) 40
Web Resource (32) 32
Publication (24) 24
Book Review (21) 21
Transcript (20) 20
Streaming Video (6) 6
Government Document (5) 5
Trade Publication Article (4) 4
Journal / eJournal (2) 2
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (83389) 83389
immunosuppressive agents - therapeutic use (52829) 52829
male (46772) 46772
female (45127) 45127
adult (31290) 31290
middle aged (28888) 28888
transplantation (24703) 24703
animals (24256) 24256
immunosuppressive agents (21206) 21206
immunosuppressive agents - adverse effects (19015) 19015
immunology (18193) 18193
treatment outcome (16906) 16906
surgery (16848) 16848
immunosuppressive agents - administration & dosage (16359) 16359
immunosuppressive agents - pharmacology (16164) 16164
aged (13975) 13975
adolescent (11800) 11800
time factors (10083) 10083
mice (10057) 10057
retrospective studies (10054) 10054
child (9589) 9589
drug therapy, combination (9556) 9556
kidney transplantation (9401) 9401
immunosuppression (9054) 9054
risk factors (8273) 8273
cyclosporine - therapeutic use (8196) 8196
cyclosporine (8054) 8054
therapy (8019) 8019
follow-up studies (7738) 7738
rats (7360) 7360
pharmacology & pharmacy (7206) 7206
tacrolimus (6813) 6813
graft rejection - prevention & control (6584) 6584
transplantation, homologous (6038) 6038
young adult (5592) 5592
immunotherapy (5423) 5423
tacrolimus - therapeutic use (5396) 5396
kidney transplantation - immunology (5383) 5383
care and treatment (5358) 5358
health aspects (5270) 5270
analysis (5205) 5205
rheumatology (5091) 5091
disease (5090) 5090
recipients (5080) 5080
research (5033) 5033
child, preschool (4980) 4980
mycophenolic acid - analogs & derivatives (4869) 4869
azathioprine - therapeutic use (4707) 4707
gastroenterology & hepatology (4669) 4669
hematology (4582) 4582
medicine, general & internal (4574) 4574
prognosis (4559) 4559
urology & nephrology (4504) 4504
biopsy (4397) 4397
kidneys (4313) 4313
dose-response relationship, drug (4275) 4275
immunosuppressive agents - pharmacokinetics (4148) 4148
prospective studies (4073) 4073
dermatology (4030) 4030
medicine & public health (3899) 3899
oncology (3882) 3882
graft survival (3866) 3866
recurrence (3866) 3866
adrenal cortex hormones - therapeutic use (3824) 3824
mycophenolic acid - therapeutic use (3815) 3815
drug therapy (3773) 3773
patients (3733) 3733
antibodies, monoclonal - therapeutic use (3722) 3722
pediatrics (3664) 3664
inflammation (3615) 3615
cyclophosphamide - therapeutic use (3611) 3611
cyclosporine - administration & dosage (3572) 3572
liver transplantation (3558) 3558
graft rejection - immunology (3556) 3556
children (3536) 3536
expression (3484) 3484
cancer (3481) 3481
kidney transplantation - adverse effects (3481) 3481
glucocorticoids - therapeutic use (3468) 3468
graft rejection (3444) 3444
diagnosis (3370) 3370
cyclosporine - adverse effects (3367) 3367
t-lymphocytes - immunology (3284) 3284
abridged index medicus (3141) 3141
rejection (3134) 3134
cyclosporine - pharmacology (3127) 3127
corticosteroids (3099) 3099
infant (3023) 3023
cells, cultured (3019) 3019
azathioprine (2997) 2997
cyclophosphamide (2975) 2975
liver (2943) 2943
graft survival - drug effects (2935) 2935
anti-inflammatory agents - therapeutic use (2931) 2931
tacrolimus - administration & dosage (2930) 2930
survival (2888) 2888
sirolimus (2883) 2883
lymphocytes (2871) 2871
efficacy (2855) 2855
prednisone - therapeutic use (2843) 2843
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (63) 63
Online Resources - Online (33) 33
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Gerstein Science - Periodical Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
Gerstein Science - May be requested in 6-10 wks (1) 1
Gerstein Science - Theses (1) 1
Media Commons - Audio Visual (1) 1
Robarts - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (101716) 101716
German (2741) 2741
French (2330) 2330
Japanese (1760) 1760
Spanish (1264) 1264
Russian (895) 895
Chinese (857) 857
Italian (611) 611
Polish (430) 430
Portuguese (355) 355
Hungarian (176) 176
Czech (141) 141
Dutch (133) 133
Romanian (115) 115
Norwegian (105) 105
Danish (95) 95
Korean (73) 73
Croatian (71) 71
Finnish (65) 65
Swedish (61) 61
Serbian (45) 45
Hebrew (35) 35
Bulgarian (33) 33
Turkish (33) 33
Ukrainian (17) 17
Slovak (16) 16
Lithuanian (12) 12
Bosnian (4) 4
Icelandic (3) 3
Slovenian (3) 3
Greek (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 4, pp. 792 - 800
Summary Hepatitis C virus (HCV) infected patients often take multiple co-medications to treat adverse events related to HCV therapy, or to manage other... 
Gastroenterology and Hepatology | Boceprevir | Hepatitis C virus infection | Telaprevir | Pharmacokinetics | Drug interactions | CHRONIC HEPATITIS-C | GASTROENTEROLOGY & HEPATOLOGY | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Hepatitis C, Chronic - metabolism | Antiviral Agents - pharmacokinetics | Hypnotics and Sedatives - adverse effects | Humans | Hypnotics and Sedatives - administration & dosage | Drug Interactions | Hypoglycemic Agents - administration & dosage | Drug Therapy, Combination | Immunosuppressive Agents - administration & dosage | Cardiovascular Agents - administration & dosage | Anti-Infective Agents - adverse effects | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Opiate Substitution Treatment - adverse effects | Buprenorphine - administration & dosage | Anti-Infective Agents - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Antiviral Agents - adverse effects | Buprenorphine - adverse effects | Antidepressive Agents - administration & dosage | Immunosuppressive Agents - adverse effects | Methadone - administration & dosage | Methadone - adverse effects | Antidepressive Agents - adverse effects | Cardiovascular Agents - adverse effects | Hypoglycemic Agents - adverse effects | Hepatitis C virus
Journal Article
Journal Article
Marine biotechnology (New York, N.Y.), ISSN 1436-2236, 2005, Volume 7, Issue 3, pp. 142 - 162
Marine sponges have been considered as a gold mine during the past 50 years, with respect to the diversity of their secondary metabolites. The biological... 
immunodeficiency-virus type-1 | alpha-glucosidase | protein-kinase-c | crambe-crambe | inositol 1,4,5-trisphosphate receptor | phospholipase a inhibitor | natural-products | antimalarial activity | acanthella-cavernosa | imidazole alkaloids | Geosciences | inflammation | natural product | sponge medicine | cancer | Oceanography | virus | Virus | Natural product | Inflammation | Sponge medicine | Cancer | ACANTHELLA-CAVERNOSA | PROTEIN-KINASE-C | PHOSPHOLIPASE A INHIBITOR | NATURAL-PRODUCTS | ALPHA-GLUCOSIDASE | INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR | CRAMBE-CRAMBE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | MARINE & FRESHWATER BIOLOGY | IMMUNODEFICIENCY-VIRUS TYPE-1 | ANTIMALARIAL ACTIVITY | IMIDAZOLE ALKALOIDS | Muscle Relaxants, Central - isolation & purification | Antifungal Agents - chemistry | Anti-Bacterial Agents - isolation & purification | Antineoplastic Agents - chemistry | Muscle Relaxants, Central - chemistry | Antifungal Agents - isolation & purification | Marine Biology | Antimalarials - isolation & purification | Animals | Anti-Inflammatory Agents - chemistry | Antineoplastic Agents - isolation & purification | Antiviral Agents - chemistry | Cardiovascular Agents - isolation & purification | Anti-Bacterial Agents - chemistry | Antimalarials - chemistry | Immunosuppressive Agents - isolation & purification | Anti-Inflammatory Agents - isolation & purification | Biological Factors - chemistry | Antiviral Agents - isolation & purification | Porifera - chemistry | Biological Factors - isolation & purification | Immunosuppressive Agents - chemistry | Cardiovascular Agents - chemistry | Metabolites | Pathogenesis | Review
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2014, Volume 121, Issue 3, pp. 785 - 796.e3
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2007, Volume 357, Issue 25, pp. 2562 - 2575
This study examines the toxicity of immunosuppressive regimens in renal-transplant recipients. A regimen containing mycophenolate mofetil, daclizumab, low-dose... 
MULTICENTER TRIAL | MEDICINE, GENERAL & INTERNAL | CYCLOSPORINE MICROEMULSION | EFFICACY | KIDNEY-TRANSPLANTATION | IMMUNOSUPPRESSION | ALLOGRAFT RECIPIENTS | TACROLIMUS | MYCOPHENOLATE-MOFETIL | SIROLIMUS | NEPHROTOXICITY | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Adrenal Cortex Hormones - therapeutic use | Enzyme Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized | Calcineurin Inhibitors | Treatment Failure | Adult | Diabetes Mellitus - etiology | Female | Drug Therapy, Combination | Mycophenolic Acid - administration & dosage | Immunosuppressive Agents - administration & dosage | Sirolimus - adverse effects | Tacrolimus - administration & dosage | Prednisone - administration & dosage | Glomerular Filtration Rate | Graft Rejection - prevention & control | Kaplan-Meier Estimate | Kidney Transplantation | Immunoglobulin G - administration & dosage | Opportunistic Infections | Sirolimus - administration & dosage | Mycophenolic Acid - analogs & derivatives | Antibodies, Monoclonal - administration & dosage | Cyclosporine - administration & dosage | Immunosuppressive Agents - adverse effects | Aged | Adrenal Cortex Hormones - administration & dosage | Transplantation | Corticosteroids | Kidneys | Research | Health aspects | Immunosuppressive agents | Medical research | Immunology | Inhibitor drugs | Transplants & implants | Toxicity | Inhibidors enzimàtics | Posologia | Ús terapèutic | Corticosteroides | Rebuig (Biologia) | Posology | Therapeutic use | Immunosupressive agents | Graft rejection | Trasplantament renal | Enzyme inhibitors | Adrenocortical hormones | Immunosupressors | Kidney transplantation | Tacrolimus: administration & dosage | Medical and Health Sciences | Graft Rejection: prevention & control | Immunoglobulin G: administration & dosage | Medicin och hälsovetenskap | Mycophenolic Acid: administration & dosage | Antibodies | Klinisk medicin | Monoclonal: administration & dosage | Prednisone: administration & dosage | Adrenal Cortex Hormones: administration & dosage | Immunosuppressive Agents: administration & dosage | Mycophenolic Acid: analogs & derivatives | Sirolimus: administration & dosage | Cyclosporine: administration & dosage | Calcineurin: antagonists & inhibitors | Diabetes Mellitus: etiology | Urologi och njurmedicin | Sirolimus: adverse effects | Adrenal Cortex Hormones: therapeutic use | Enzyme Inhibitors: administration & dosage | Immunosuppressive Agents: adverse effects | Clinical Medicine | Immunosuppressive Agents: therapeutic use | Urology and Nephrology
Journal Article
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2015, Volume 15, Issue 12, pp. 1429 - 1437
Summary Background The declining efficacy of existing antibiotics potentially jeopardises outcomes in patients undergoing medical procedures. We investigated... 
Infectious Disease | INFECTIOUS DISEASES | SURGICAL SITE INFECTIONS | VANCOMYCIN | BACTEREMIA | STAPHYLOCOCCUS-AUREUS | COMPLICATIONS | COLONIZATION | GUIDED PROSTATE BIOPSY | ANTIMICROBIAL RESISTANCE | CARE | ENTEROBACTERIACEAE | Anti-Bacterial Agents - economics | Neoplasms - surgery | Opportunistic Infections - surgery | Humans | Immunosuppressive Agents - therapeutic use | Neoplasms - microbiology | Neoplasms - mortality | Surgical Wound Infection - mortality | Fluoroquinolones - therapeutic use | Opportunistic Infections - mortality | Antineoplastic Agents - therapeutic use | Surgical Wound Infection - surgery | Models, Statistical | Antineoplastic Agents - economics | Neoplasms - drug therapy | Opportunistic Infections - microbiology | Randomized Controlled Trials as Topic | Anti-Bacterial Agents - therapeutic use | Fluoroquinolones - economics | Surgical Wound Infection - drug therapy | Opportunistic Infections - drug therapy | Surgical Wound Infection - microbiology | Immunosuppressive Agents - economics | Antimitotic agents | Drug resistance in microorganisms | Chemotherapy | Evolutionary biology | Surgery | Oncology, Experimental | Models | Research | Drug therapy | Antineoplastic agents | Cancer | Bacterial infections | Mortality | Infections | Cancer therapies | Clinical outcomes | Meta-analysis | Studies | Literature reviews | Hospitals | Fractures | Antibiotics | E coli | Biopsy | Patient safety | Back surgery | Pharmacists | Colorectal surgery
Journal Article